Accumulating evidence has revealed that the inhibition of AGTR1 by antagonists such as losartan [30, 31] and candesartan [32] can suppress angiogenesis, thereby contributing to the suppression of tumor growth and blood metastasis. The gene discussed is AGTR1; the disease is neoplasm.